Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Functional cure

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Dec 17, 2021 12:48pm

163 Views

Post# 34241140

RE:RE:RE:RE:Functional cure

MS agree hopefully we get more on the next stage in Jan. Witowski is the saving grace for this company and with any luck the poor management decisions will be diluted with overwhelming success in the science.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?